Colonization of these bacteria in tumors increases the intratumoral L-arginine concentration and promotes effector T-cell function, thereby synergistically enhancing the efficacy of the anti-PD-L1 therapy and forming long-lasting anti-tumor immunity. This evidence concerns the gene CD274 and neoplasm.